While SAA1 serves as an acute-phase protein produced in large quantities in response to injury, infection, and inflammation [46], S100B, a Ca2+ binding protein predominantly derived from astrocytes, has been widely recognized as a putative biomarker of brain injury [47] and, only more recently, as a possible neuroinflammatory mediator [48]. The gene discussed is S100B; the disease is infection.